Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.Fed Regist. 2000 Jan 03; 65(1):7-9.FR
Abstract
The Food and Drug Administration (FDA) is amending the regulation that established a standardized format and standardized content requirements for the labeling of over-the-counter (OTC) drug products, and is amending several related OTC drug product labeling regulations. This amendment corrects and conforms several aspects of the new labeling requirements to other regulatory provisions and eliminates unnecessary text from the new labeling regulation.
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
11010625
Citation
"Over-the-counter Human Drugs; Labeling Requirements; Final Rule; Technical Amendment. Food and Drug Administration, HHS. Final Rule; Technical Amendment." Federal Register, vol. 65, no. 1, 2000, pp. 7-9.
Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment. Fed Regist. 2000;65(1):7-9.
(2000). Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment. Federal Register, 65(1), 7-9.
Over-the-counter Human Drugs; Labeling Requirements; Final Rule; Technical Amendment. Food and Drug Administration, HHS. Final Rule; Technical Amendment. Fed Regist. 2000 Jan 3;65(1):7-9. PubMed PMID: 11010625.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
PY - 2000/9/30/pubmed
PY - 2000/9/30/medline
PY - 2000/9/30/entrez
SP - 7
EP - 9
JF - Federal register
JO - Fed Regist
VL - 65
IS - 1
N2 - The Food and Drug Administration (FDA) is amending the regulation that established a standardized format and standardized content requirements for the labeling of over-the-counter (OTC) drug products, and is amending several related OTC drug product labeling regulations. This amendment corrects and conforms several aspects of the new labeling requirements to other regulatory provisions and eliminates unnecessary text from the new labeling regulation.
SN - 0097-6326
UR - https://www.unboundmedicine.com/medline/citation/11010625/Over_the_counter_human_drugs
DB - PRIME
DP - Unbound Medicine
ER -